Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
51.64-0.67 (-1.28%)
At close: 04:03PM EDT
51.65 +0.01 (+0.02%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close52.31
Open51.75
Bid51.50 x 1200
Ask51.63 x 1100
Day's Range50.40 - 51.89
52 Week Range38.93 - 61.71
Volume17,022,503
Avg. Volume24,386,440
Market Cap289.747B
Beta (5Y Monthly)0.71
PE Ratio (TTM)11.63
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.60 (3.06%)
Ex-Dividend DateJul 28, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pfizer, Inc.
    Technical Assessment: Bearish in the Intermediate-TermMonday provided a much-needed rest for the stock market after a very large rebound last week. Following that strong week (and we've seen this before during the current decline), the "bottom-callers" are out, but not in big numbers. That's probably a good thing, as others are calling this another bear-market rally. From a technical perspective and using our own interpretation, it is far too early to call the bottom as there is just not enough of the needed evidence.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
Advertisement
Advertisement